Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epoetin Alfa in Metastatic Breast Cancer Anemia
NCT00338286Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Mar 2006
- Primary completion
- Jul 2014
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 21
01
Overview
A Phase 3 trial of epoetin alfa in anemia, sponsored by Janssen Pharmaceutical. Started Mar 2006; status: completed.
02
Drugs
epoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00338286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00338286.